MyCEI Login


From Abstract to Concrete: Co-infections, Comorbidities and Complications from CROI 2024


Published Date: 04/22/2024

Expiration Date: 03/18/2027

CE Credit: CME:1


This year we are pleased to announce that PRN will expand its coverage of CROI 2024, with Marshall Glesby focusing on other important highlights, including co-infections, comorbidities and complications.


Marshall J. Glesby,MD, PhD

Marshall Glesby, MD, PhD is a Professor of Medicine and Population Health Sciences, Associate Chief of the Division of Infectious Diseases, and Vice Chair for Mentoring and Faculty Development in the Department of Medicine at Weill Cornell Medical College. He is also the Director of the Cornell HIV Clinical Trials Unit and Regional Clinical Director of the Northeast Caribbean AIDS Education and Training Center. Dr. Glesby is a graduate of the Johns Hopkins University School of Medicine and completed his internal medicine residency and infectious diseases fellowship at the Johns Hopkins Hospital. He also has a Ph.D. in Clinical Investigation from the Johns Hopkins School of Hygiene and Public Health. He is an Assistant Editor of the Journal of Acquired Immune Deficiency Syndromes and a former member of the Antiviral Drugs Advisory Committee of the Food and Drug Administration (FDA). His research program focuses on cardiopulmonary, metabolic, and aging-related complications and co-morbidities in people with HIV. He has co-authored over 150 peer reviewed publications.

Learning Objectives

  • Be able to summarize data on cardiometabolic risk reduction in people with HIV.
  • Be aware of trends in cancer incidence and strategies for prevention among people with HIV.
  • Understand the latest data on aging-related complications in people with HIV.

Continuing Education Credit Information